维普中文期刊产品整合服务
34篇 您的检索式:作者名="Turpie B"
    题名 作者 年代 出处 被引量
1Sjogren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice显示文摘Turpie B Yoshimura T Gulati A 2009Am J Pathol2009,175,3:1
2Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial显示文摘Turpie A G Lassen M R Davidson B L 2009Lancet2009,373,9676:1
3Venous thromboembolism:pathophysiology,clinical features,and prevention显示文摘Turpie A G G Chin B S P Lip G Y H 2002BMJ2002,325,7369:1
4临床怀疑深静脉血栓形成病人的压迫超声诊断:前瞻性队列研究显示文摘目的:评价临床上怀疑为深静脉血栓形成但压迫超声显像所见正常病人不给予肝素治疗的安全性。设计:根据一种简化的程序来做压迫超声显像,超声显像的部位限于3处,即腹股沟部的股总静脉、腘静脉及胭静脉远端小腿静脉的分叉部位。初诊时超声显像为正常的病人1周后再重复检查1次。评价结果的标准:对于临床上怀疑为深静脉血栓形成的病人,凡是间隔1周两次超声显像均正常者则不予以肝素治疗,随访6个月,统计在这段时间内静脉血栓栓塞合并症的发生率。参加单位:四所大学附属医院的研究中心。结果:本研究共包括1702名病人,第一次检查发现400名血栓形成者,第二次检查又发现12名,因此用超声诊断方法在该1702名临床上怀疑为深静脉血栓形成的病人中确诊了412例,占24%。全组病人均获得随访,在两次 B 超检查之间,有1例发生了静脉血栓性栓塞的合并症,在6个月随访期间又有8例,所以累计发生率为0.7%(95%可信限为0.3%~1.2%),登门随访及补做检查的次数为平均每例0.8次。结论:对于临床上怀疑为深静脉血栓形成的病人,若连续两次压迫超声检查均为正常者,不给予肝素治疗是安全的。Alberto Cogo Anthonie W A Lensing Maria M W Koopman Franco Piovella Sergio Siragusa Philip S Wells Sabina Villalta Harry R Bller Alexander G G Turpie Paolo Prandoni 冷希圣 1998英国医学杂志中文版1998,0,1:1
5Benefit -risk assessment of rivaroxa- ban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty 显示文摘Levitan B Yuan Z Turpie AG 2014Vasc Health Risk Manag2014,10,2:1
6Rivarox- aban versus enoxaparin for thromboprophylaxis after total knee arthroplasty(RECORD4) : a randomised tri- al显示文摘Turpie A G Lassen M R Davidson B L 2009Lancet2009,373,9676:1
7Riva- roxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty ( RECORD4 ) : a randomised tria显示文摘TURPIE A G LASSEN M R DAVIDSON B L 2009Lancet2009,373,9676:1
8Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty显示文摘Levitan B Yuan Z Turpie AG 2014Vasc Health Risk Manag2014,10,:1
9Rivaroxaban for the prevention of venous thromboembolism after hip or knee atqhroplasty 显示文摘Turpie A G G Lassen M R Eriksson B I 2011Thromb Haemost2011,105,3:1
10Riva-roxaban versus enoxaparin for thromboprophylaxis after totalknee arthroplasty (RECORD4): a randomised trial 显示文摘TURPIE A G LASSEN M R DAVIDSON B L 2009Lancet2009,373,9676:1
11Sj~gren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice显示文摘Turpie B Yoshimura T Gulati A 2009Am J Pathol2009,175,:1
12A randomized eval-uation of betrixaban,an oral factor Xa inhibitor,for prevention of thromboembolic events after total knee replacement(EXPERT)显示文摘Turpie A G Bauer K A Davidson B L 2009Thromb Haemost2009,101,1:1
13Sj(o)gren's syndromelike ocular surface disease in thrombospondin-1 deficient mice显示文摘Turpie B Yoshimura T Gulati A 2009Am J Pathol2009,175,:1
14Venous thromboembolism:treatment strategies显示文摘Turpie A G G Chin B S P Lip G Y H 2002BJM2002,325,3070:1
15Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD 4) : a randomized trial 显示文摘Turpie A Lassen M Davidson B 2009Lancet2009,373,9676:1
16A randomized evaluation of betrixaban, an oral factor X a inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT) 显示文摘Turpie A G Bauer K A Davidson B L 2009Thromb Haemost2009,101,1:1
17A dose escalation study of YMI50, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery 显示文摘Eriksson B I Turpie A G Lassen M R 2007J Thromb Haemost2007,5,8:1
18A randomized eval- uation of betrixaban, an oral factor Xa inhibilor, for prevention of thromboembolic events after total knee replacement (EXPERT) 显示文摘Turpie A G Bauer K A Davidson B L 2009Thromb Haemost2009,101,1:1
19A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the preven- tion of venous thromboembolism in elective primary hip replace- ment surgery显示文摘Eriksson B I Turpie A G Lassen M R 2007J Thromb Haemost2007,5,8:1
20Rivaroxaban versus enoxapa- rin for thromboprophylaxis after total knee arthroplasty (RE- CORD4): a randomised trial显示文摘Turpie A Lassen M Davidson B 2009Lancet2009,373,9676:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费